SCHEMBL9198992

SCHEMBL9198992

CC(C)C(c1ccc2ncc(=O)[nH]c2c1)n1ccnc1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.47
CYP11B2 P19099 3/20 0.47
CYP17A1 P05093 4/20 0.47
CYP26A1 O43174 6/20 0.40
CYP3A4 P08684 6/20 0.40
CYP19A1 P11511 2/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP24A1 Q07973 1/20 0.40
CYP26B1 Q9NR63 1/20 0.40
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
CNR1 P21554 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9198062 0.91 CYP11B1 (0.47) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL9728123 0.80 CYP17A1 (0.45) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL27352418 0.79 CYP11B1 (0.47) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL9192257 0.78 KDM4E (0.44) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL9192629 0.77 CYP17A1 (0.43) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL27352420 0.77 CYP11B1 (0.47) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL9190861 0.76 CYP17A1 (0.56) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL9191072 0.76 CYP17A1 (0.42) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL9190836 0.76 CYP17A1 (0.57) CYP11B1CYP11B2CYP17A1CYP26A1CYP3A4
SCHEMBL31526691 0.75 MAPKAPK2 (0.46) CYP3A4CYP2C8CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 EP disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 US disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 EP disclosed